Manufacturer profile

Hi pharma

Every published regulatory action recorded against this manufacturer, across all African authorities Drug Eye Africa monitors. Built strictly from published regulatory decisions and nothing else.

What these numbers are. They are counts of published regulatory actions recorded on this register. They are not a finding about the company, not an allegation, and not a measure of product quality. A manufacturer appearing here has had actions published against named products by named authorities; the actions speak for themselves and each one links to its primary notice.

Recorded actions

Countries

Authorities

Class I actions recorded

Recorded actions

2 shown

Reference	Date	Country	Product	Batches	Action	Class	Source
DEA-EG-2025-0093	Dec 2025	EG	Nasostop 0.05% nasal drops for pediatrics Hi pharma	0740324	Recall	Class II	Tier 1 · Regulator-published
DEA-EG-2025-0070	Oct 2025	EG	Nasostop0.1% nasal drops for adults Hi pharma	0830324	Recall	Class II	Tier 1 · Regulator-published

Counts are of published regulatory actions recorded on this register. They are not a finding about the company, and this page says so.

Names as published

The issuing authorities published this name as: Hi pharma.

Company response

Drug Eye Africa has not yet invited a response from this company. That is our omission and not the company’s silence, and it is recorded here as one.

A company named on this page may write to notices@drugeyeafrica.org. A response is published beside these records in full, and the request is logged either way. Nothing on this page is a finding about the company: each entry is an action a named authority published, and it links to that authority’s own notice.

How this page is built

Published regulator decisions only — no press reports, no allegations
Name matching is conservative: only corporate-form suffixes are stripped, and a name that would reduce to a single token is kept whole
Every action links to its primary notice

This profile as data

/api/v1/manufacturers/hi-pharma